WED-597 Safety, pharmacokinetics, pharmacodynamics, and antiviral activity of cavrotolimod, alone and in combination with low-dose nivolumab, for the treatment of chronic hepatitis B
Grace Lai-Hung Wong, Man-Fung Yuen, Hassan Javanbakht(Harvard University), Marta Dobryanska, Paul B. Eckburg, Alina Jucov, Jacinta Holmes, Bobby Asem, Edward J. Gane, Susanna K. Tan, Jerome Deval, Loghman Salimzadeh, Simone Strasser, Eternity Labio, Stuart K. Roberts, Nancy Shulman, Adam Gehring, Leesun Kim(Ulsan National Institute of Science and Technology)
Cited by 0
Related Papers
IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines
|Nature Immunology|2022|529
Macrophage- and Dendritic-Cell-Derived Interleukin-15 Receptor Alpha Supports Homeostasis of Distinct CD8+ T Cell Subsets
|Immunity|2009|224
<i>Toxoplasma gondii</i> Tachyzoites Inhibit Proinflammatory Cytokine Induction in Infected Macrophages by Preventing Nuclear Translocation of the Transcription Factor NF-κB
|The Journal of Immunology|2001|217
Review of the QuEChERS method for the analysis of organic pollutants: Persistent organic pollutants, polycyclic aromatic hydrocarbons, and pharmaceuticals
|Trends in Environmental Analytical Chemistry|2019|209
Cutting Edge: IL-10-Independent STAT3 Activation by <i>Toxoplasma gondii</i> Mediates Suppression of IL-12 and TNF-α in Host Macrophages
|The Journal of Immunology|2005|160